Abstract
Psoriasis is a chronic, systemic, inflammatory skin disease with a risk of comorbidities and a potential high impact on patients’ quality of life.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of drugs in dermatology : JDD |
| Vol/bind | 19 |
| Udgave nummer | 3 |
| Sider (fra-til) | 316-318 |
| Antal sider | 3 |
| ISSN | 1545-9616 |
| Status | Udgivet - 1 mar. 2020 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Real World SB4 (Etanercept Biosimilar) Use in Patients With Psoriasis: Data from the British Association of Dermatologists Biologic Interventions Register (BADBIR)'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS